229 related articles for article (PubMed ID: 32954315)
1. 11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial.
Markey K; Mitchell J; Botfield H; Ottridge RS; Matthews T; Krishnan A; Woolley R; Westgate C; Yiangou A; Alimajstorovic Z; Shah P; Rick C; Ives N; Taylor AE; Gilligan LC; Jenkinson C; Arlt W; Scotton W; Fairclough RJ; Singhal R; Stewart PM; Tomlinson JW; Lavery GG; Mollan SP; Sinclair AJ
Brain Commun; 2020; 2(1):fcz050. PubMed ID: 32954315
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial.
Markey KA; Ottridge R; Mitchell JL; Rick C; Woolley R; Ives N; Nightingale P; Sinclair AJ
JMIR Res Protoc; 2017 Sep; 6(9):e181. PubMed ID: 28923789
[TBL] [Abstract][Full Text] [Related]
3. 11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension.
Hardy RS; Botfield H; Markey K; Mitchell JL; Alimajstorovic Z; Westgate CSJ; Sagmeister M; Fairclough RJ; Ottridge RS; Yiangou A; Storbeck KH; Taylor AE; Gilligan LC; Arlt W; Stewart PM; Tomlinson JW; Mollan SP; Lavery GG; Sinclair AJ
J Clin Endocrinol Metab; 2021 Jan; 106(1):174-187. PubMed ID: 33098644
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 11β-Hydroxysteroid dehydrogenase-1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, phase II study.
Yadav Y; Dunagan K; Khot R; Venkatesh SK; Port J; Galderisi A; Cobelli C; Wegner C; Basu A; Carter R; Basu R
Diabetes Obes Metab; 2022 May; 24(5):881-890. PubMed ID: 35014156
[TBL] [Abstract][Full Text] [Related]
5. Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial.
Ajjan RA; Hensor EMA; Del Galdo F; Shams K; Abbas A; Fairclough RJ; Webber L; Pegg L; Freeman A; Taylor AE; Arlt W; Morgan AW; Tahrani AA; Stewart PM; Russell DA; Tiganescu A
Eur J Endocrinol; 2022 Feb; 186(4):441-455. PubMed ID: 35113805
[TBL] [Abstract][Full Text] [Related]
6. Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal Osteopenia.
Abbas A; Schini M; Ainsworth G; Brown SR; Oughton J; Crowley RK; Cooper MS; Fairclough RJ; Eastell R; Stewart PM
J Clin Endocrinol Metab; 2022 Jun; 107(7):2026-2035. PubMed ID: 35275196
[TBL] [Abstract][Full Text] [Related]
7. 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial.
Othonos N; Pofi R; Arvaniti A; White S; Bonaventura I; Nikolaou N; Moolla A; Marjot T; Stimson RH; van Beek AP; van Faassen M; Isidori AM; Bateman E; Sadler R; Karpe F; Stewart PM; Webster C; Duffy J; Eastell R; Gossiel F; Cornfield T; Hodson L; Jane Escott K; Whittaker A; Kirik U; Coleman RL; Scott CAB; Milton JE; Agbaje O; Holman RR; Tomlinson JW
Nat Commun; 2023 Feb; 14(1):1025. PubMed ID: 36823106
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension.
Rauz S; Cheung CM; Wood PJ; Coca-Prados M; Walker EA; Murray PI; Stewart PM
QJM; 2003 Jul; 96(7):481-90. PubMed ID: 12881590
[TBL] [Abstract][Full Text] [Related]
9. Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure.
Grech O; Clouter A; Mitchell JL; Alimajstorovic Z; Ottridge RS; Yiangou A; Roque M; Tahrani AA; Nicholls M; Taylor AE; Shaheen F; Arlt W; Lavery GG; Shapiro K; Mollan SP; Sinclair AJ
Brain Commun; 2021; 3(3):fcab202. PubMed ID: 34704028
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation?
Sinclair AJ; Walker EA; Burdon MA; van Beek AP; Kema IP; Hughes BA; Murray PI; Nightingale PG; Stewart PM; Rauz S; Tomlinson JW
J Clin Endocrinol Metab; 2010 Dec; 95(12):5348-56. PubMed ID: 20826586
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial.
Stefan N; Ramsauer M; Jordan P; Nowotny B; Kantartzis K; Machann J; Hwang JH; Nowotny P; Kahl S; Harreiter J; Hornemann S; Sanyal AJ; Stewart PM; Pfeiffer AF; Kautzky-Willer A; Roden M; Häring HU; Fürst-Recktenwald S
Lancet Diabetes Endocrinol; 2014 May; 2(5):406-16. PubMed ID: 24795254
[TBL] [Abstract][Full Text] [Related]
12. Modulation of 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity biomarkers and pharmacokinetics of PF-00915275, a selective 11betaHSD1 inhibitor.
Courtney R; Stewart PM; Toh M; Ndongo MN; Calle RA; Hirshberg B
J Clin Endocrinol Metab; 2008 Feb; 93(2):550-6. PubMed ID: 17986636
[TBL] [Abstract][Full Text] [Related]
13. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
Homma M; Tanaka A; Hino K; Takamura H; Hirano T; Oka K; Kanazawa M; Miwa T; Notoya Y; Niitsuma T; Hayashi T
Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
[TBL] [Abstract][Full Text] [Related]
14. Experimental drugs for the treatment of idiopathic intracranial hypertension (IIH): shedding light on phase I and II trials.
Khatkar P; Hubbard JC; Hill L; Sinclair AJ; Mollan SP
Expert Opin Investig Drugs; 2023; 32(12):1123-1131. PubMed ID: 38006580
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical Trial.
Mollan SP; Mitchell JL; Ottridge RS; Aguiar M; Yiangou A; Alimajstorovic Z; Cartwright DM; Grech O; Lavery GG; Westgate CSJ; Vijay V; Scotton W; Wakerley BR; Matthews TD; Ansons A; Hickman SJ; Benzimra J; Rick C; Singhal R; Tahrani AA; Brock K; Frew E; Sinclair AJ
JAMA Neurol; 2021 Jun; 78(6):678-686. PubMed ID: 33900360
[TBL] [Abstract][Full Text] [Related]
16. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study.
Sinclair AJ; Burdon MA; Nightingale PG; Ball AK; Good P; Matthews TD; Jacks A; Lawden M; Clarke CE; Stewart PM; Walker EA; Tomlinson JW; Rauz S
BMJ; 2010 Jul; 341():c2701. PubMed ID: 20610512
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic-pharmacodynamic studies of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor MK-0916 in healthy subjects.
Wright DH; Stone JA; Crumley TM; Wenning L; Zheng W; Yan K; Yang AY; Sun L; Cilissen C; Ramael S; Hermanowski-Vosatka A; Langdon RB; Gottesdiener KM; Wagner JA; Lai E
Br J Clin Pharmacol; 2013 Dec; 76(6):917-31. PubMed ID: 23594227
[TBL] [Abstract][Full Text] [Related]
18. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
[TBL] [Abstract][Full Text] [Related]
19. Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.
Wirostko BM; Tressler C; Hwang LJ; Burgess G; Laties AM
BMJ; 2012 Feb; 344():e554. PubMed ID: 22354598
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.
Tomlinson JW; Sherlock M; Hughes B; Hughes SV; Kilvington F; Bartlett W; Courtney R; Rejto P; Carley W; Stewart PM
J Clin Endocrinol Metab; 2007 Mar; 92(3):857-64. PubMed ID: 17200165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
